Cargando…

Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical Cancer

Cervical cancer caused by human papillomavirus (HPV) infections is the fourth most common cancer in women worldwide. Current prophylactic HPV vaccines have achieved promising success in preventing HPV infection. However, still 570,000 new cases were reported in 2018. The current primary treatment fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Bilian, Zhu, Linjing, Wei, Hongxia, Shi, Haixia, Zhang, Doudou, Yuan, Huanyun, Luan, Linlin, Zheng, Nan, Xu, Shijie, Nawaz, Waqas, Hong, Ying, Wu, Xilin, Wu, Zhiwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264373/ https://www.ncbi.nlm.nih.gov/pubmed/34248960 http://dx.doi.org/10.3389/fimmu.2021.678318

Ejemplares similares

A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
por: Wu, Xilin, et al.
Publicado: (2021)

AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia
por: Nawaz, Waqas, et al.
Publicado: (2021)

Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)
por: Wu, Xilin, et al.
Publicado: (2022)

Induction of neutralizing antibodies by human papillomavirus vaccine generated in mammalian cells
por: Wu, Xilin, et al.
Publicado: (2019)

Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome
por: Xu, Shijie, et al.
Publicado: (2021)

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers
por: Chang, J T-C, et al.
Publicado: (2010)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro
por: Reddout, Nicole, et al.
Publicado: (2007)

Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008)

A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model
por: Yin, Fei, et al.
Publicado: (2017)

Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
por: Pérez, Sonia, et al.
Publicado: (2014)

A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()
por: Vasiljević, Nataša, et al.
Publicado: (2014)

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody
por: Wang, Daning, et al.
Publicado: (2015)

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers
por: Wang, Xueyin, et al.
Publicado: (2021)

Neutralization Epitopes in Trimer and Pentamer Complexes Recognized by Potent Cytomegalovirus-Neutralizing Human Monoclonal Antibodies
por: Ai, Yuanbao, et al.
Publicado: (2022)

Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high‐risk HPV‐positive women
por: Chen, Xiaojun, et al.
Publicado: (2019)

HPV 18 variants in women with cervical cancer in Northeast Brazil
por: Santos, Gerusinete Rodrigues Bastos dos, et al.
Publicado: (2022)

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors
por: Damm, Oliver, et al.
Publicado: (2009)

HPV16/18 genotyping for the triage of HPV positive women in primary cervical cancer screening in Chile
por: Lagos, Marcela, et al.
Publicado: (2015)

Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali
por: Téguété, Ibrahima, et al.
Publicado: (2017)

The correlation of HPV16 and HPV18 with local vaginal immunity after the treatment of cervical intraepithelial neoplasia
por: Mu, Lin, et al.
Publicado: (2020)

Building resilient cervical cancer prevention through gender-neutral HPV vaccination
por: Man, Irene, et al.
Publicado: (2023)

Evolution and Taxonomic Classification of Alphapapillomavirus 7 Complete Genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70
por: Chen, Zigui, et al.
Publicado: (2013)

HPV DNA methylation at the early promoter and E1/E2 integrity: A comparison between HPV16, HPV18 and HPV45 in cervical cancer
por: Amaro-Filho, Sérgio Menezes, et al.
Publicado: (2018)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Triage of HPV-positive women in Norway using cytology, HPV16/18 genotyping and HPV persistence
por: Arbyn, Marc, et al.
Publicado: (2020)

HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation
por: Yu, Lulu, et al.
Publicado: (2022)

Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
por: Mariz, Filipe Colaço, et al.
Publicado: (2020)

Structural basis for neutralization of an anicteric hepatitis associated echovirus by a potent neutralizing antibody
por: Feng, Rui, et al.
Publicado: (2021)

Development and characterization of an HPV18 detection kit using two novel HPV18 type-specific monoclonal antibodies
por: Zhang, Yao, et al.
Publicado: (2018)

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs
por: Huang, Weijin, et al.
Publicado: (2020)

Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013)

HPV16 and HPV18 type-specific APOBEC3 and integration profiles in different diagnostic categories of cervical samples
por: Lagström, Sonja, et al.
Publicado: (2021)

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential
por: Gai, Junwei, et al.
Publicado: (2021)

Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71
por: Zhu, Ling, et al.
Publicado: (2018)

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
por: So, Kyeong A, et al.
Publicado: (2016)

Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis
por: Zheng, Changwei, et al.
Publicado: (2015)

Rapid detection of high-risk HPV16 and HPV18 based on microchip electrophoresis
por: Fan, Zhaoxuan, et al.
Publicado: (2020)

Membranous and nuclear staining of CLDN18 in HPV‐independent and HPV‐associated endocervical adenocarcinomas
por: Du, Xiuzhen, et al.
Publicado: (2022)

Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71
por: Chen, Zhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ebrecsai0m6b1gbtl0qgmoic5